Characteristic | ||
---|---|---|
No. of patients | 47 | |
Age (year, mean ± SD) | 73.6 ± 7.02 | |
Initial PSA (median ± SD) | 11.1 ± 489.1 ng/ml | |
Stage | No. of patients | |
T1cN0M0 | 8 | 17% |
T2N0M0 | 14 | 29.8% |
T3N0M0 | 9 | 19.1% |
T4N0M0 | 2 | 4.3% |
TanyN1M0 | 4 | 8.5% |
TanyN0M1 | 5 | 10.6% |
TanyN1M1 | 5 | 10.6% |
Metastasis | ||
All distant metastasis | 10 | 21.2% |
Bone metastasis | 7 | 14.9% |
Visceral metastasis | 3 | 6.4% |
Gleason Score | ||
GS 6 | 4 | 9% |
GS 7 | 15 | 32% |
GS≧8 | 28 | 59% |